Article View: be.science
Article #391Cancer - Press review (July 16, 2011) – Revue de presse (16 juillet 2011)
From: SciMedWeb
Date: Sat, 16 Jul 2011 08:38
Date: Sat, 16 Jul 2011 08:38
213 lines
10583 bytes
10583 bytes
Cancer – Press Review – Revue de Presse Every week on http://marclacroixcancerblog.blogspot.com Chaque semaine sur http://marclacroixcancerblog.blogspot.com Press review (July 16, 2011) – Revue de presse (16 juillet 2011) Study: More U.S. men die from cancer than women Men in the United States are much more likely than women to die of cancer, a new report from the U.S. National Cancer Institute found. By Steven Reinberg. In USA Today http://yourlife.usatoday.com/health/medical/cancer/story/2011/07/Study-More-US-men-die-from-cancer-than-women/49347822/1?csp=34news Family History of Cancer Needs to Be Updated as You Age Study shows it can lead to needed changes in screening. By Denise Mann. In U.S. News & World Report http://health.usnews.com/health-news/family-health/cancer/articles/2011/07/12/family-history-of-cancer-needs-to-be-updated-as-you-age US girls sweep Google kids science fair Three US girls won the top prizes in a global science fair launched by Google for their projects on ovarian cancer, grilled chicken and indoor air quality, the Internet giant announced Tuesday. AFP http://www.google.com/hostednews/afp/article/ALeqM5hXBy_tE0n-oaHT0X40ESLUQHPGmg?docId=CNG.1a520310fd53287b78bc3c012e7eae10.781 After styrene warning, concern about who's at risk Duffy Mitchell has cut fiberglass, slathered epoxy resin and twisted rubber hoses at his boat repair shop here on the Chesapeake Bay for more than a dozen years. By Ernest Scheyder. Reuters http://www.reuters.com/article/2011/07/13/us-styrene-idUSTRE76C31K20110713 Scientists Spot Possible Target in Ovarian Cancer Researchers seeking a way to beat cancer have found that a particular gene, known as PAX8, is altered in a significant number of ovarian tumors, according to a new study. The research is part of Project Achilles, a comprehensive effort by scientists from the Broad Institute of MIT and Harvard, and the Dana-Farber Cancer Institute to identify weaknesses in cancers. In U.S. News & World Report http://health.usnews.com/health-news/family-health/cancer/articles/2011/07/12/scientists-spot-possible-target-in-ovarian-cancer ICGC Releases New Genomic Data on Cancer Ahead of Schedule The International Cancer Genome Consortium (ICGC) today announced its sixth major data release at a meeting in Kyoto, Japan. The ICGC also announced that it is ahead of schedule in its decade-long goal to generate high-quality genomic data on more than 25,000 tumors for up to 50 types of cancer that are of clinical and societal importance across the globe. PR Newswire (press release) http://www.prnewswire.com/news-releases/icgc-releases-new-genomic-data-on-cancer-ahead-of-schedule-125349918.html Bladder Cancer Patients Not Getting Recommended Care: Study Most patients with a certain type of bladder cancer don't get the recommended treatments, which greatly increases their risk of experiencing a recurrence of their disease, researchers say. By Denise Mann. In U.S. News & World Report http://health.usnews.com/health-news/managing-your-healthcare/cancer/articles/2011/07/12/bladder-cancer-patients-not-getting-recommended-care-study Study explains why men are at higher risk for stomach cancer MIT researchers show how estrogen protects women from the gastric inflammation that can lead to cancer. By Anne Trafton. MIT News http://web.mit.edu/newsoffice/2011/gastric-cancer-0713.html Nigeria: The Cervical Cancer Challenge RECENT reports of the serious challenge posed by cervical cancer, especially in the developing world, which many people are so ignorant of, are alarming, and the scourge must be tackled head on. AllAfrica.com http://allafrica.com/stories/201107120953.html Hormone therapy shown to prolong life for some prostate cancer patients Men diagnosed with prostate cancer are routinely given a harsh hormone therapy treatment for four months -- it suppresses the production of the male sex hormone testosterone -- but little was known about how effective that treatment was at increasing the odds of survival in those with early- and intermediate-stage disease. So researchers decided to test whether giving the drugs along with radiation treatments could prolong a patient’s life. By Deborah Kotz. In Boston Globe http://www.boston.com/Boston/dailydose/2011/07/hormone-therapy-shown-prolong-life-for-some-prostate-cancer-patients/CKy5xqnSnf3xsAOGzKOH1O/index.html Roche's pertuzumab helps breast cancer patients‎ Patients with advanced breast cancer lived significantly longer without their disease getting worse when treated with Roche's pertuzumab and Herceptin along with a type of chemotherapy, a late- stage study showed. By Katie Reid, Will Waterman. Reuters http://www.reuters.com/article/2011/07/15/roche-idUSLDE76E01S20110715 Study suggests new way to attack resistant tumours‎ UK scientists have shown that a particular group of chemotherapy drugs work by causing an unusual form of cell death in cancer cells, called necroptosis. Cancer Research UK http://info.cancerresearchuk.org/news/archive/cancernews/2011-07-14-Study-suggests-new-way-to-attack-resistant-tumours- Vaccin contre le cancer du col de l’utérus : le Gardasil remis en cause Alors que le Gardasil, un des deux vaccins contre le cancer du col de l’utérus, disponible en France depuis novembre 2006, est décrié par un collectif de médecins réunionnais, les premières demandes d’indemnisation voient le jour. Par Florence Bozec. Dans Futura-Sciences http://www.futura-sciences.com/fr/news/t/medecine/d/vaccin-contre-le-cancer-du-col-de-luterus-le-gardasil-remis-en-cause_31375/ Cancer : 365.000 nouveaux cas en 2011 d'après l'INVS En 2011, 365.000 personnes s'entendront dire qu'elles ont une tumeur. C'est ce que prévoit l'Institut de veille sanitaire. Le chiffre représente une légère hausse, de 2,2 %, par rapport à 2010. Dans Futura-Sciences http://www.futura-sciences.com/fr/news/t/medecine/d/cancer-365000-nouveaux-cas-en-2011-dapres-linvs_31355/ Perturbateurs endocriniens: protéger les mères et les enfants d'abord Etiqueter des produits contenant des perturbateurs endocriniens pour protéger les plus vulnérables, les bébés et les femmes enceintes: un rapport parlementaire, publié mercredi, propose d'agir, sans attendre, au nom du principe de précaution. De Brigitte Castelnau. AFP http://www.google.com/hostednews/afp/article/ALeqM5h2y3dtMJ2JiQlG1AS-i-qG2rvyzw?docId=CNG.2ea01b29a14a71a024e3f1e79f1e3e05.6e1 Roche prévoit demande d'homologation pour le pertuzumab (cancer du sein HER2) Roche a atteint ses objectifs d'étude de phase III (CLEOPATRA) avec le médicament pertuzumab lors de traitement du cancer du sein HER2. Les résultats de l'étude doivent être présentés cette année encore aux autorités de la santé au niveau mondial, a indiqué Roche vendredi dans un communiqué. Le pertuzumab doit être utilisé en combinaison avec l’herceptin et le docetaxel. Dans Romandie.com http://www.romandie.com/news/n/Roche_prevoit_demande_d_homologation_pour_Pertuzumab_cancer_du_sein_HER2_dev150720111007.asp "Pour les nuls" propose un nouveau guide pour mieux comprendre le cancer La série des Nuls s'agrandit avec un nouveau guide pratique, entièrement dédié à tous les types de cancers. Proposé par les Editions First, cet ouvrage répond à toutes les questions que peuvent se poser les patients et leur entourage sur le cancer, et tente de lutter contre les idées reçues. Dans Le Parisien http://www.leparisien.fr/laparisienne/sante/pour-les-nuls-propose-un-nouveau-guide-pour-mieux-comprendre-le-cancer-13-07-2011-1532703.php Santé et internet: un nouveau "savoir profane" émerge des réseaux sociaux L'essor d'internet et des réseaux sociaux de santé fait émerger un nouveau savoir collectif, ou "profane", au côté du savoir médical, transformant la relation malade-médecin mais aussi la façon dont est vécue la maladie, selon une enquête réalisée par des sociologues. Par Véronique Martinache. AFP http://www.google.com/hostednews/afp/article/ALeqM5iGAnf-O3Gj1-nv7z-uMWgEgBvQpw?docId=CNG.f924baf2a7e4381be48d55dfd841115b.371 Augmentation alarmante des cas du cancer du sein : 1006 nouveaux cas cette année et trois ablations chaque semaine Le taux d’incidence, c’est-à -dire le nombre de nouveaux cas, de cette maladie à Oran, est de 20 cas pour 100.000 femmes. Dans El Watan http://www.elwatan.com/regions/ouest/oran/1-006-nouveaux-cas-cette-annee-et-trois-ablations-chaque-semaine-14-07-2011-132607_135.php Cancer Blog – Marc Lacroix – Le Blogue du Cancer http://marclacroixcancerblog.blogspot.com Marc Lacroix – Oncowal & Wallogene (07/2011)
Technical Details
Message-ID:
<dfaf9f73-0b66-4234-aee2-78650d6753f2@q1g2000vbj.googlegroups.com>Path:
arc1-ca.pugleaf.net!g2news1.google.com!postnews.google.com!q1g2000vbj.googlegroups.com!not-for-mailShow Full Headers
Complete Article Headers
X-Google-Thread: a254ea4a8d,58fa3c2483e2b956,start X-Google-Attributes: gida254ea4a8d,public,usenet X-Google-NewGroupId: yes X-Google-Language: ENGLISH,UTF8 Path: arc1-ca.pugleaf.net!g2news1.google.com!postnews.google.com!q1g2000vbj.googlegroups.com!not-for-mail From: SciMedWeb <scimedweb@mail.com> Newsgroups: be.science Subject: Cancer - Press review (July 16, 2011) – Revue de presse (16 juillet 2011) Date: Sat, 16 Jul 2011 01:38:58 -0700 (PDT) Organization: http://groups.google.com Lines: 213 Message-ID: <dfaf9f73-0b66-4234-aee2-78650d6753f2@q1g2000vbj.googlegroups.com> NNTP-Posting-Host: 81.247.49.77 Mime-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: quoted-printable X-Trace: posting.google.com 1310806474 13622 127.0.0.1 (16 Jul 2011 08:54:34 GMT) X-Complaints-To: groups-abuse@google.com NNTP-Posting-Date: Sat, 16 Jul 2011 08:54:34 +0000 (UTC) Complaints-To: groups-abuse@google.com Injection-Info: q1g2000vbj.googlegroups.com; posting-host=81.247.49.77; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE User-Agent: G2/1.0 X-Google-Web-Client: true X-Google-Header-Order: UHALERCNK X-HTTP-UserAgent: Opera/9.80 (Windows NT 5.1; U; fr) Presto/2.8.131 Version/11.11,gzip(gfe)